Perpetual Ltd lifted its stake in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 147.2% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 8,154 shares of the company's stock after purchasing an additional 4,856 shares during the quarter. Perpetual Ltd's holdings in Docusign were worth $664,000 as of its most recent SEC filing.
Other hedge funds also recently modified their holdings of the company. Golden State Wealth Management LLC grew its stake in Docusign by 519.4% during the first quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock worth $31,000 after buying an additional 322 shares in the last quarter. Wood Tarver Financial Group LLC bought a new position in Docusign in the fourth quarter valued at approximately $37,000. MassMutual Private Wealth & Trust FSB raised its position in Docusign by 153.1% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 453 shares of the company's stock valued at $37,000 after purchasing an additional 274 shares in the last quarter. McIlrath & Eck LLC lifted its stake in Docusign by 476.0% during the fourth quarter. McIlrath & Eck LLC now owns 432 shares of the company's stock worth $39,000 after purchasing an additional 357 shares during the last quarter. Finally, Bessemer Group Inc. boosted its holdings in shares of Docusign by 490.0% in the 4th quarter. Bessemer Group Inc. now owns 472 shares of the company's stock valued at $42,000 after purchasing an additional 392 shares in the last quarter. Institutional investors own 77.64% of the company's stock.
Insider Transactions at Docusign
In other news, insider James P. Shaughnessy sold 7,500 shares of the firm's stock in a transaction that occurred on Tuesday, April 1st. The shares were sold at an average price of $81.31, for a total transaction of $609,825.00. Following the completion of the sale, the insider now owns 45,875 shares of the company's stock, valued at $3,730,096.25. This trade represents a 14.05% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Teresa Briggs sold 534 shares of the business's stock in a transaction on Monday, June 16th. The shares were sold at an average price of $74.37, for a total transaction of $39,713.58. Following the transaction, the director now owns 8,805 shares in the company, valued at $654,827.85. The trade was a 5.72% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 54,052 shares of company stock valued at $4,101,776. Corporate insiders own 1.01% of the company's stock.
Analyst Ratings Changes
A number of equities analysts have recently commented on DOCU shares. Hsbc Global Res raised Docusign from a "moderate sell" rating to a "hold" rating in a report on Friday, April 11th. Morgan Stanley dropped their target price on shares of Docusign from $92.00 to $86.00 and set an "equal weight" rating for the company in a report on Friday, June 6th. Royal Bank Of Canada reaffirmed a "sector perform" rating and set a $90.00 target price on shares of Docusign in a research note on Friday, March 14th. Robert W. Baird reduced their price objective on Docusign from $93.00 to $85.00 and set a "neutral" rating on the stock in a research report on Friday, June 6th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Docusign in a research report on Friday, June 6th. Twelve investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $89.77.
Read Our Latest Report on Docusign
Docusign Stock Performance
NASDAQ:DOCU opened at $76.47 on Friday. Docusign Inc. has a fifty-two week low of $48.80 and a fifty-two week high of $107.86. The company has a 50 day simple moving average of $82.17 and a two-hundred day simple moving average of $85.11. The company has a market capitalization of $15.45 billion, a PE ratio of 14.46, a P/E/G ratio of 29.00 and a beta of 1.14.
Docusign (NASDAQ:DOCU - Get Free Report) last posted its quarterly earnings data on Thursday, June 5th. The company reported $0.90 earnings per share for the quarter, topping the consensus estimate of $0.81 by $0.09. The company had revenue of $763.65 million during the quarter, compared to analysts' expectations of $748.79 million. Docusign had a net margin of 36.50% and a return on equity of 14.27%. Docusign's revenue for the quarter was up 7.6% compared to the same quarter last year. During the same period in the prior year, the company posted $0.82 earnings per share. Research analysts predict that Docusign Inc. will post 1.17 EPS for the current year.
Docusign announced that its Board of Directors has approved a share repurchase plan on Thursday, June 5th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the company to repurchase up to 6.6% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's board of directors believes its stock is undervalued.
Docusign Profile
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.